Free Trial
LON:TILS

Tiziana Life Sciences (TILS) Share Price, News & Analysis

GBX 58.50
+4.50 (+8.33%)
(As of 10/20/2021)
Today's Range
45
59
50-Day Range
58.50
58.50
52-Week Range
30
195
Volume
297,127 shs
Average Volume
522,223 shs
Market Capitalization
£113.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TILS stock logo

About Tiziana Life Sciences Stock (LON:TILS)

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. The company also develops anti-IL6R (TZLS-501), a human anti-interleukin-6 receptor monoclonal antibody for the treatment of IL6-induced inflammation, primarily to treat COVID-19 patients with severe respiratory symptoms. It has a collaboration agreement with FHI Clinical Inc. to conduct a phase 2 clinical trial for treating hospitalized severe COVID-19 patients with intranasal foralumab, a human anti-CD3 monoclonal antibody. The company was incorporated in 1998 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.

TILS Stock Price History

TILS Stock News Headlines

Tiziana Life Sciences Ltd (0RP)
Tiziana Life Sciences CEO purchases shares
Tiziana Life Sciences
Advan Co Ltd (7463)
Tiziana Life Sciences: Multiple Sclerosis single study
See More Headlines
Receive TILS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tiziana Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/30/2020
Today
5/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£-3,595,000.00
Cash Flow
GBX 25.70 per share
Book Value
GBX 23.50 per share

Miscellaneous

Free Float
N/A
Market Cap
£113.85 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Gabriele Marco Antonio Cerrone M.B.A. (Age 49)
    MBA, Founder & Exec. Chairman
    Comp: $13.76M
  • Dr. Kunwar Shailubhai (Age 63)
    CEO, Chief Scientific Officer & Exec. Director
    Comp: $810k
  • Dr. Andrea Brancale
    Scientific Founder
  • Mr. Richard Clarkson Ph.D.
    Scientific Founder
  • Mr. Andrew Westwell Ph.D.
    Scientific Founder
  • Ms. Keeren Shah (Age 44)
    Fin. Director
  • Dr. Thomas H. Adams (Age 78)
    Head of Drug Devel. & Exec. Director
  • Dr. Neil Graham M.P.H. (Age 62)
    MBBS, M.D., MPH, Chief Medical Officer
  • Dr. Napoleone Ferrara (Age 63)
    Chairman of Scientific Advisory Board
  • Prof. Roberto Pellicciari
    Consultant

TILS Stock Analysis - Frequently Asked Questions

How have TILS shares performed in 2024?

Tiziana Life Sciences' stock was trading at GBX 58.50 on January 1st, 2024. Since then, TILS stock has increased by 0.0% and is now trading at GBX 58.50.
View the best growth stocks for 2024 here
.

How were Tiziana Life Sciences' earnings last quarter?

Tiziana Life Sciences PLC (LON:TILS) issued its quarterly earnings results on Wednesday, September, 30th. The biotechnology company reported ($2.60) earnings per share for the quarter, topping analysts' consensus estimates of ($4.00) by $1.40.

What other stocks do shareholders of Tiziana Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Synergy Pharmaceuticals (SGYP), Micron Technology (MU), ServiceNow (NOW), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Dropbox (DBX), Enterprise Products Partners (EPD) and Franco-Nevada (FNV).

How do I buy shares of Tiziana Life Sciences?

Shares of TILS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:TILS) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners